Evolution of the human methylome in blood from embryo to ageing and cancer
By reconstructing the evolutionary history of the human blood methylome across the lifespan using single-cell sequencing, this study reveals that heritable methylation changes occur at rates vastly exceeding DNA mutations, creating a pervasive mosaic of "embryonic epialleles" that drive somatic evolution, influence epigenetic aging, and serve as substrates for clonal expansion and cancer.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Every cell in the human body carries a copy of the same genetic instruction manual, yet a skin cell looks and acts nothing like a blood cell. This difference is not written in the letters of the DNA code itself, but in a layer of chemical tags that sit on top of the DNA, acting like switches that turn genes on or off. One of the most important of these tags is a tiny chemical group called a methyl group. When a methyl group attaches to a specific spot on the DNA, it usually silences the gene nearby, preventing it from being read. These tags are copied every time a cell divides, passing the cell's identity down to its children. Because they are copied so faithfully, scientists have long suspected that the pattern of these tags holds a hidden record of a cell's history, much like a tree ring records a tree's growth. However, until now, no one had been able to watch this record being written in real time across a human life, from the very first cell divisions in an embryo to the complex, aging tissues of an adult, or to see how these patterns change when blood cancer takes hold.
A team of researchers at the Wellcome Sanger Institute and their collaborators have now reconstructed this history with unprecedented detail. They did not look at a mixture of cells from a blood sample, which would blur the distinct histories of individual cells together. Instead, they took single blood stem cells from thirteen different people—ranging from a seventeen-week-old fetus to a seventy-seven-year-old adult, and including identical twins—and grew them in the lab until each single cell became a large colony of millions of descendants. They then sequenced the DNA and the methyl tags of every single colony. By comparing the genetic mutations and the methyl tags across these colonies, they could build a family tree for each donor, tracing every cell back to its origin. This allowed them to see exactly when and where specific chemical tags changed, and to distinguish between changes that happened naturally as the body grew and changes that occurred later in life.
The researchers discovered that the chemical tags on DNA change far more frequently than the DNA letters themselves. Before a baby is born, the rate at which these tags change is six million times faster than the rate at which the DNA code mutates. After birth, this rate slows down but remains four thousand times faster than DNA mutation. Most of these changes happen in large blocks, affecting dozens or even hundreds of chemical tags at once, rather than changing them one by one. By the time a baby is born, every single blood cell already carries about three hundred thousand of these chemical changes. Many of these changes are stable and persist for decades, creating a permanent mosaic of different chemical patterns within the blood of a single person. The researchers call these stable, inherited patterns "embryonic epialleles." They found that these patterns are so common that a single person can have about two hundred and fifty thousand of them, and many of these patterns appear in different people, suggesting they are a standard part of human development.
This deep history of chemical changes has profound implications for how we understand aging and disease. Scientists have previously used patterns of these chemical tags to create "epigenetic clocks," which estimate a person's biological age based on their blood. The new study shows that these clocks do not actually measure the passage of time in the way we think. Instead, they measure how many times the cells in a blood sample have divided. If a person has a clone of blood cells that is dividing rapidly, such as in a pre-cancerous condition or leukemia, the epigenetic clock will show that the person is biologically much older than they actually are. In one striking example, a patient with a rapidly dividing blood cancer appeared to be thirty-five years older than their actual age. When that patient was successfully treated and the cancer cells were eliminated, their epigenetic age dropped by thirty-five years over just four years, even though they were getting older in real time. This proves that the clock is tracking the division history of the dominant cells, not the age of the person.
The study also revealed how blood cancers arise and evolve. When a dangerous clone of cells expands to take over the blood, it often carries with it the chemical patterns established in the embryo, making it difficult to tell which changes caused the cancer and which were just inherited. However, the researchers found a few specific instances where new chemical changes appeared only in the cancer cells and seemed to drive the disease. In one case, a cancer cell gained a chemical tag that turned off a gene known to suppress tumors. In another, a tag was lost from a gene that controls calcium channels, potentially helping the cancer cells grow. These changes were not random accidents; they appeared in multiple patients with the same type of cancer, suggesting that the cancer cells actively selected for these chemical switches to help them survive and multiply.
Perhaps the most surprising finding was the ability to pinpoint the exact moment in development when certain critical decisions are made. By looking at the chemical patterns on the X chromosome in female donors, the researchers were able to trace the exact cell division when one of the two X chromosomes is permanently silenced to balance gene dosage. They determined that this happens within the first few cell divisions after fertilization, confirming long-held theories about early human development. They also found that in one patient with a rare blood cancer, the protective mechanisms that usually keep chemical tags stable failed during the very first few divisions of life, leading to widespread errors in the chemical code that persisted for decades.
The work demonstrates that the chemical landscape of our cells is not a static background but a dynamic, evolving record of our life history. It shows that the diversity of chemical patterns established in the womb creates a complex mosaic that influences how our cells behave throughout our lives. This mosaic provides a rich substrate for evolution within the body, where cells can compete and adapt not just through changes in their DNA code, but through changes in the chemical switches that control their genes. By reading this chemical history, scientists can now distinguish between the normal, stable patterns of development and the specific, dangerous changes that drive disease, offering a new way to understand the origins of blood disorders and the true nature of cellular aging.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.